NLRP3 and Alzheimer disease: RIG-1, a component of inflammasome signaling, is elevated in plasma and temporal cortex in mild cognitive impairment (MCI, frequently a precursor syndrome of AD) subjects (de Rivero Vaccari et al., 2014) Therefore, many lines of evidence suggest the NLRP3 inflammasome is relevant to AD.